IL131613A0 - Microbial biotransformation - Google Patents

Microbial biotransformation

Info

Publication number
IL131613A0
IL131613A0 IL13161399A IL13161399A IL131613A0 IL 131613 A0 IL131613 A0 IL 131613A0 IL 13161399 A IL13161399 A IL 13161399A IL 13161399 A IL13161399 A IL 13161399A IL 131613 A0 IL131613 A0 IL 131613A0
Authority
IL
Israel
Prior art keywords
microbial biotransformation
biotransformation
microbial
Prior art date
Application number
IL13161399A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to IL15353499A priority Critical patent/IL153534A/xx
Publication of IL131613A0 publication Critical patent/IL131613A0/xx
Priority to IL15353402A priority patent/IL153534A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13161399A 1998-08-28 1999-08-26 Microbial biotransformation IL131613A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL15353499A IL153534A (en) 1998-08-28 1999-08-26 Microbial biotransformation
IL15353402A IL153534A0 (en) 1998-08-28 2002-12-19 Microbial biotransformation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9825598P 1998-08-28 1998-08-28

Publications (1)

Publication Number Publication Date
IL131613A0 true IL131613A0 (en) 2001-01-28

Family

ID=22268411

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13161399A IL131613A0 (en) 1998-08-28 1999-08-26 Microbial biotransformation

Country Status (26)

Country Link
EP (1) EP0989187B1 (xx)
JP (2) JP3103539B2 (xx)
KR (1) KR100338917B1 (xx)
CN (2) CN1271209C (xx)
AR (1) AR016505A1 (xx)
AT (1) ATE380251T1 (xx)
AU (1) AU749873B2 (xx)
BR (1) BR9903971A (xx)
CA (1) CA2280994C (xx)
CY (1) CY1107291T1 (xx)
CZ (1) CZ298476B6 (xx)
DE (1) DE69937662T2 (xx)
DK (1) DK0989187T3 (xx)
ES (1) ES2297913T3 (xx)
HK (2) HK1028068A1 (xx)
HU (1) HU226215B1 (xx)
ID (1) ID23459A (xx)
IL (1) IL131613A0 (xx)
IN (1) IN191812B (xx)
PL (1) PL197322B1 (xx)
PT (1) PT989187E (xx)
RU (1) RU2203954C2 (xx)
TR (1) TR199902097A2 (xx)
TW (1) TWI225096B (xx)
YU (1) YU40599A (xx)
ZA (1) ZA995489B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2274854T3 (es) * 2000-05-08 2007-06-01 Pfizer Products Inc. Resolucion enzimatica de moduladores selectivos del receptor de estrogeno.

Also Published As

Publication number Publication date
AU749873B2 (en) 2002-07-04
YU40599A (sh) 2002-03-18
AU4482599A (en) 2000-03-16
HK1028068A1 (en) 2001-02-02
JP2000279189A (ja) 2000-10-10
CN1271209C (zh) 2006-08-23
JP3103539B2 (ja) 2000-10-30
TR199902097A2 (xx) 2000-03-21
CZ298476B6 (cs) 2007-10-17
PT989187E (pt) 2008-02-21
BR9903971A (pt) 2000-10-17
TWI225096B (en) 2004-12-11
DK0989187T3 (da) 2008-01-28
PL335149A1 (en) 2000-03-13
HUP9902903A3 (en) 2002-09-30
ES2297913T3 (es) 2008-05-01
PL197322B1 (pl) 2008-03-31
CN1177935C (zh) 2004-12-01
HUP9902903A2 (en) 2000-07-28
JP2000069989A (ja) 2000-03-07
EP0989187B1 (en) 2007-12-05
RU2203954C2 (ru) 2003-05-10
HK1068373A1 (en) 2005-04-29
KR20000017603A (ko) 2000-03-25
AR016505A1 (es) 2001-07-04
DE69937662T2 (de) 2008-04-10
CY1107291T1 (el) 2012-11-21
DE69937662D1 (de) 2008-01-17
CZ308099A3 (cs) 2000-03-15
IN191812B (xx) 2004-01-03
KR100338917B1 (ko) 2002-05-30
CA2280994A1 (en) 2000-02-28
CN1259577A (zh) 2000-07-12
EP0989187A2 (en) 2000-03-29
CA2280994C (en) 2002-12-24
HU9902903D0 (en) 1999-10-28
EP0989187A3 (en) 2001-06-13
ID23459A (id) 2000-04-27
HU226215B1 (en) 2008-06-30
ZA995489B (en) 2001-02-26
CN1552883A (zh) 2004-12-08
ATE380251T1 (de) 2007-12-15

Similar Documents

Publication Publication Date Title
DE69909613D1 (en) Bicyclische hydroxamsäurederivate
EP1021972A4 (en) WRITING DESK
GB9804835D0 (en) Predistorter
DE69904335D1 (en) Aminomethylcarbonsäurederivate
DE59914151D1 (en) Arylalkanoylpyridazine
GB9804745D0 (en) Predistorter
TW394296U (en) Markierungselement
HK1068373A1 (en) Microbial biotransformation
GB9800867D0 (en) Bearing
IL153534A (en) Microbial biotransformation
GB9803239D0 (en) Easygrip
GB2335813B (en) Predistorter
GB2339003B (en) Movement-damping arrangements
GB9826122D0 (en) Microorganism
GB2340966B (en) Golfing aid
CA83750S (en) Golfing aid
GB9810227D0 (en) Uses
GB9810226D0 (en) Uses
GB9817025D0 (en) Chiropody training aid
GB9910046D0 (en) Desk
PL107699U1 (en) Desk
GB9809830D0 (en) Desk
GR2002094Y (en) Time-table
GB9822866D0 (en) Staticmat
GB9819810D0 (en) Homeball

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees